Does FOSTAMATINIB Cause Neutrophil count decreased? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Neutrophil count decreased have been filed in association with FOSTAMATINIB (TAVALISSE). This represents 0.3% of all adverse event reports for FOSTAMATINIB.
16
Reports of Neutrophil count decreased with FOSTAMATINIB
0.3%
of all FOSTAMATINIB reports
7
Deaths
6
Hospitalizations
How Dangerous Is Neutrophil count decreased From FOSTAMATINIB?
Of the 16 reports, 7 (43.8%) resulted in death, 6 (37.5%) required hospitalization, and 1 (6.3%) were considered life-threatening.
Is Neutrophil count decreased Listed in the Official Label?
Yes, Neutrophil count decreased is listed as a known adverse reaction in the official FDA drug label for FOSTAMATINIB.
What Other Side Effects Does FOSTAMATINIB Cause?
Diarrhoea (904)
Platelet count decreased (804)
Product dose omission issue (711)
Off label use (680)
Hospitalisation (403)
Platelet count (375)
Drug ineffective (340)
Fatigue (332)
Blood pressure increased (314)
Death (307)
What Other Drugs Cause Neutrophil count decreased?
CLOZAPINE (2,523)
LENALIDOMIDE (2,471)
PALBOCICLIB (2,224)
CYCLOPHOSPHAMIDE (1,985)
CARBOPLATIN (1,734)
PACLITAXEL (1,562)
RITUXIMAB (1,509)
DEXAMETHASONE (1,320)
BEVACIZUMAB (1,225)
POMALIDOMIDE (1,062)
Which FOSTAMATINIB Alternatives Have Lower Neutrophil count decreased Risk?
FOSTAMATINIB vs FOSTEMSAVIR TROMETHAMINE
FOSTAMATINIB vs FOTEMUSTINE
FOSTAMATINIB vs FRAMYCETIN
FOSTAMATINIB vs FREMANEZUMAB
FOSTAMATINIB vs FREMANEZUMAB-VFRM